170 related articles for article (PubMed ID: 17615398)
1. Effects of palliative radiation therapy on nonsplenic hemangiosarcoma in dogs.
Hillers KR; Lana SE; Fuller CR; LaRue SM
J Am Anim Hosp Assoc; 2007; 43(4):187-92. PubMed ID: 17615398
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of outcome associated with subcutaneous and intramuscular hemangiosarcoma treated with adjuvant doxorubicin in dogs: 21 cases (2001-2006).
Bulakowski EJ; Philibert JC; Siegel S; Clifford CA; Risbon R; Zivin K; Cronin KL
J Am Vet Med Assoc; 2008 Jul; 233(1):122-8. PubMed ID: 18593321
[TBL] [Abstract][Full Text] [Related]
3. Prognosis for dogs with stage I or II splenic hemangiosarcoma treated by splenectomy alone: 32 cases (1991-1993).
Wood CA; Moore AS; Gliatto JM; Ablin LA; Berg RJ; Rand WM
J Am Anim Hosp Assoc; 1998; 34(5):417-21. PubMed ID: 9728473
[TBL] [Abstract][Full Text] [Related]
4. Hemangiosarcomas.
Brown NO
Vet Clin North Am Small Anim Pract; 1985 May; 15(3):569-75. PubMed ID: 3874469
[No Abstract] [Full Text] [Related]
5. Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997-2004).
Kim SE; Liptak JM; Gall TT; Monteith GJ; Woods JP
J Am Vet Med Assoc; 2007 Nov; 231(10):1550-7. PubMed ID: 18021000
[TBL] [Abstract][Full Text] [Related]
6. Infiltrative lipoma in dogs: 16 cases (1981-1992).
Bergman PJ; Withrow SJ; Straw RC; Powers BE
J Am Vet Med Assoc; 1994 Jul; 205(2):322-4. PubMed ID: 7928612
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of doxorubicin-based chemotherapy for non-resectable canine subcutaneous haemangiosarcoma.
Wiley JL; Rook KA; Clifford CA; Gregor TP; Sorenmo KU
Vet Comp Oncol; 2010 Sep; 8(3):221-33. PubMed ID: 20691029
[TBL] [Abstract][Full Text] [Related]
8. Four-fraction radiation therapy for macroscopic soft tissue sarcomas in 16 dogs.
Lawrence J; Forrest L; Adams W; Vail D; Thamm D
J Am Anim Hosp Assoc; 2008; 44(3):100-8. PubMed ID: 18451067
[TBL] [Abstract][Full Text] [Related]
9. Survival time of dogs with splenic hemangiosarcoma treated by splenectomy with or without adjuvant chemotherapy: 208 cases (2001-2012).
Wendelburg KM; Price LL; Burgess KE; Lyons JA; Lew FH; Berg J
J Am Vet Med Assoc; 2015 Aug; 247(4):393-403. PubMed ID: 26225611
[TBL] [Abstract][Full Text] [Related]
10. Marginal excision of low-grade spindle cell sarcoma of canine extremities: 35 dogs (1996-2006).
Stefanello D; Morello E; Roccabianca P; Iussich S; Nassuato C; Martano M; Squassino C; Avallone G; Romussi S; Buracco P
Vet Surg; 2008 Jul; 37(5):461-5. PubMed ID: 18986313
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of clinical and histologic factors associated with survival time in dogs with stage II splenic hemangiosarcoma treated by splenectomy and adjuvant chemotherapy: 30 cases (2011-2014).
Moore AS; Rassnick KM; Frimberger AE
J Am Vet Med Assoc; 2017 Sep; 251(5):559-565. PubMed ID: 28828962
[TBL] [Abstract][Full Text] [Related]
12. Primary rib tumors in 54 dogs.
Pirkey-Ehrhart N; Withrow SJ; Straw RC; Ehrhart EJ; Page RL; Hottinger HL; Hahn KA; Morrison WB; Albrecht MR; Hedlund CS
J Am Anim Hosp Assoc; 1995; 31(1):65-9. PubMed ID: 7820767
[TBL] [Abstract][Full Text] [Related]
13. Oncologic outcome after curative-intent treatment in 39 dogs with primary chest wall tumors (1992-2005).
Liptak JM; Kamstock DA; Dernell WS; Monteith GJ; Rizzo SA; Withrow SJ
Vet Surg; 2008 Jul; 37(5):488-96. PubMed ID: 18986317
[TBL] [Abstract][Full Text] [Related]
14. Palliation of clinical signs in 48 dogs with nasal carcinomas treated with coarse-fraction radiation therapy.
Gieger T; Rassnick K; Siegel S; Proulx D; Bergman P; Anderson C; LaDue T; Smith A; Northrup N; Roberts R
J Am Anim Hosp Assoc; 2008; 44(3):116-23. PubMed ID: 18451069
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of tumour-related factors associated with canine retroperitoneal hemangiosarcoma in comparison with other anatomic presentations: A retrospective observational study.
Furukawa T; Shiotsuki A; Okada Y; Nibe K; Tei M; Anazawa T; Yoshikawa M; Ono K; Hirao H
Vet Med Sci; 2024 Jul; 10(4):e1495. PubMed ID: 38889089
[TBL] [Abstract][Full Text] [Related]
16. Predictors of outcome in dogs with subcutaneous or intramuscular hemangiosarcoma.
Shiu KB; Flory AB; Anderson CL; Wypij J; Saba C; Wilson H; Kurzman I; Chun R
J Am Vet Med Assoc; 2011 Feb; 238(4):472-9. PubMed ID: 21320017
[TBL] [Abstract][Full Text] [Related]
17. Acute nontraumatic hemoabdomen in the dog: a retrospective analysis of 39 cases (1987-2001).
Pintar J; Breitschwerdt EB; Hardie EM; Spaulding KA
J Am Anim Hosp Assoc; 2003; 39(6):518-22. PubMed ID: 14736714
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986-1996).
Kuntz CA; Dernell WS; Powers BE; Devitt C; Straw RC; Withrow SJ
J Am Vet Med Assoc; 1997 Nov; 211(9):1147-51. PubMed ID: 9364229
[TBL] [Abstract][Full Text] [Related]
19. Treatment of retroperitoneal sarcoma results in improved outcomes.
Walter KM; Culp WTN; Giuffrida MA; Amsellem P; Wallace ML; Grimes JA; Wustefeld-Janssens B; O'Neill M; Withers SS; Shannon D; Lapsley J; Tuohy J; Hixson H; Lux CN; Matz B; Selmic LE; McGrath A; Griffin MA; Mayhew PD; Steffey MA; Balsa IM; Rebhun RB; Kent MS
J Am Vet Med Assoc; 2024 Jul; 262(7):1-9. PubMed ID: 38382204
[TBL] [Abstract][Full Text] [Related]
20. Canine hemangiosarcoma: retrospective analysis of 104 cases.
Brown NO; Patnaik AK; MacEwen EG
J Am Vet Med Assoc; 1985 Jan; 186(1):56-8. PubMed ID: 4038395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
